Skip to content

Antibacterial clothing study

Pragmatic randomized controlled multi center trial comparing the effectiveness of antibacterial therapeutic clothing based on silver or chitosan as compared with non-antibacterial therapeutic clothing in patients with moderate to severe atopic dermatitis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25728
Enrollment
165
Registered
2019-08-28
Start date
2020-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

The control group will receive non-antimicrobial therapeutic clothing. The chitosan group will receive antimicrobial therapeutic clothing based on chitosan The silver group will receive antimicrobial

Sponsors

Erasmus MC
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - AD diagnosed according to the criteria of Williams (Williams 1994); - Age 0 - 80 years; - AD severity according to EASI at t = 0 >6.0.

Exclusion criteria

Exclusion criteria: - Treatment with oral antibiotics until 1 month before inclusion; - Treatment with topical antibiotics until 1 week before inclusion; - Treatment with systemic immunosuppressive agents or light therapy until 1 month before inclusion; - Treatment with (antibacterial) therapeutic clothing until 1 month before inclusion; - Impaired kidney function (anamnestic assessed) - Pregnancy or pregnancy wish during study (anamnestic assessed) - Hypersensitivity to silver (anamnestic assessed) - Evidence of past non-compliance to treatments or appointments.

Design outcomes

Primary

MeasureTime frame
Difference in disease severity measured by the EASI by between the clothing without antimicrobial agents (control group) and microbial growth reducing/ antimicrobial clothing based on chitosan or silver (intervention groups) over 12 months

Secondary

MeasureTime frame
- Difference in corticosteroid ointment or cream between the clothing without antimicrobial agents (control group) and microbial growth reducing/ antimicrobial clothing based on chitosan or silver (intervention groups) assessed in the periods, 0 - 1 months, 1 - 3 months, 3 - 6 months, 6 - 12 months - Difference in investigator global assessment between the clothing without antimicrobial agents (control group) and microbial growth reducing/ antimicrobial clothing based on chitosan or silver (intervention groups) assessed in the periods, 0 - 1 months, 1 - 3 months, 3 - 6 months, 6 - 12 months - Difference in patient global assessment between the clothing without antimicrobial agents (control group) and microbial growth reducing/ antimicrobial clothing based on chitosan or silver (intervention groups) assessed in the periods, 0 - 1 months, 1 - 3 months, 3 - 6 months, 6 - 12 months - Difference in global assessment of degree of impetiginisation (pustules, oozing, crust formation) of dermatitis between the clothing without antimicrobial agents (control group) and microbial growth reducing/ antimicrobial clothing based on chitosan or silver (intervention groups), expressed as 0 – no impetiginisation, 1 – sporadic impetiginisation, 2 – mild impetiginisation, 3 – moderate impetiginisation, 4 – severe impetiginisation - Difference in S. aureus colonization (semi-quantitative culture) between the clothing without antimicrobial agents (control group) and microbial growth reducing/ antimicrobial clothing based on chitosan or silver (intervention groups) over 12 months; - Difference in POEM or POEM for proxy completion in the case of children up to 10 years of age by their parents between the clothing without antimicrobial agents (control group) and microbial growth reducing/ antimicrobial clothing based on chitosan or silver (intervention groups) over 12 monhts - Difference in IDLQI18 years between the clothing without antimicrobial agents (control group) and microbial grow

Contacts

Public ContactSuzanne Pasmans

ErasmusMC

s.pasmans@erasmusmc.nl0031653524299

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)